Article
Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification.
FEBS letters - 13 Feb 1998
Mackness B, Mackness M I, Arrol S, Turkie W, Durrington P N
Abstract excerpt
Human serum paraoxonase (PON1) associated with high density lipoprotein (HDL) has been postulated to have a role in protecting low density lipoprotein (LDL) against oxidative modification, which has led to the proposal that PON1 is an anti-atherogenic, anti-inflammatory enzyme. PON1 has two genet...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
